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TObjective: Many patients with cancer have limited esophageal reconstruction op-
tions when the stomach is unavailable as a replacement conduit or when long-
segment discontinuity exists. Jejunum has been used as an alternative conduit, both
as a pedicled or free flap interposition; however, reports of this are usually limited
to short-segment repairs. Microvascular augmentation of a pedicled jejunal flap
allows creation of a longer conduit, making it possible to replace the entire
esophagus with jejunum. Few reports describe this technique in patients with cancer.
We report our initial experience with “supercharged” pedicled jejunum as an
alternative conduit for total esophageal reconstruction.
Methods: Review of a prospectively collected departmental database was performed
to identify those patients who underwent total esophageal reconstruction with
supercharged pedicled jejunum. Data regarding their perioperative course and
postoperative function were gathered from the prospectively collected clinical data,
review of hospital records, and patient interviews.
Results: Total esophageal reconstruction with supercharged pedicled jejunum was
attempted in 26 patients (age range, 37-74 years) between March 2000 and April
2004. Twenty-four of 26 patients were ultimately discharged with an intact super-
charged pedicled jejunum flap, for an overall success rate of 92.3%. One patient
experienced intraoperative flap loss caused by technical difficulties harvesting the
flap and never had the flap interposed. One other flap loss occurred in the early
postoperative period in a patient who had multisystem organ failure after a pro-
longed reconstruction. Cervical anastomotic leaks occurred in 19.2% (5/26) of the
patients. Two midconduit leaks occurred that were suspicious for iatrogenic perfo-
ration from nasogastric tube placement; one required reoperation. One additional
early reoperation was performed for cecal ischemia. There were no mortalities.
Functional results were available in 95.4% (21/22) of the patients receiving super-
charged pedicled jejunum who survived at least 6 months after reconstruction. At
the time of follow-up, 95% (20/21) of the patients were tolerating regular diet, and
76.2% (16/21) did not require any supplemental alimentation. Ninety-five percent
(20/21) of the patients were free from reflux symptoms, and 80.9% (17/21) had no
dumping symptoms. Only 1 patient required dilation of a midconduit stricture. One
patient required late reoperation for conduit redundancy.
Conclusions: Supercharged pedicled jejunum is a suitable alternative conduit for
total esophageal replacement in patients with cancer with otherwise limited recon-
structive options. Functional outcomes are excellent, despite the severity of disease
and technical challenges in this patient population.
Esophageal reconstruction remains a challenge, even in the most experiencedhands. Although the stomach is widely considered the reconstructive conduitof choice, especially after cancer operations, its use as an esophageal
replacement has inherent limitations that can potentially affect a patient’s functional
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is simply not available as a replacement conduit because of
disease involvement or prior gastric surgery.
The use of a pedicled colon interposition to replace the
esophagus is well described in the literature, and this con-
duit might avoid some of the long-term side effects of
gastric pull-up procedures. However, this technique also has
several distinct disadvantages, including an increased need
for remedial procedures when compared with gastric con-
duits.1-5 Similarly, the colon might be unavailable because
of a previous operation or intrinsic diseases, such as diver-
ticulosis, polyps, or cancer.
The jejunum might represent the final alternative for
esophageal reconstruction in some patients and offers sev-
eral potential advantages when compared with the stomach
and colon. Jejunum is readily available, is generally free of
intrinsic disease, closely approximates the diameter of the
esophagus, and might maintain intrinsic aboral peristalsis
after transfer. Despite these attributes, the use of jejunum
has mainly been limited to partial esophageal reconstruc-
tions with pedicled interpositions because of the limitations
of the mesenteric blood supply.
Advances in microsurgical technique have now ex-
panded the role of the jejunum in esophageal reconstruction,
allowing for the creation of longer conduits through “super-
charging.” This involves microvascular augmentation of the
proximal mesenteric circulation of a jejunal flap through an
anastomosis with the internal thoracic or cervical vessels,
making it possible to replace the entire esophagus with
jejunum. This report represents our initial experience with
supercharged pedicled jejunum (SPJ) as an alternative con-
duit for total esophageal reconstruction.
Patients and Methods
After approval by our institutional review board, we conducted an
analysis of 293 patients who underwent esophagectomy at our
institution between March 2000 and April 2004. Retrospective
review of our departmental database (consisting of prospectively
defined data elements collected concurrently with clinical care of
the individual patient) allowed identification of those patients who
underwent total esophageal reconstruction with an SPJ flap during
that time period. Data regarding their preoperative characteristics
and perioperative course were gathered through analysis of the
aforementioned database and subsequent review of hospital
records. Information on jejunal conduit function was collected on
patients who survived at least 6 months after their reconstruction.
The 6-month time period provided patients with an opportunity to
recover from their operations and adjust to their new anatomy.
Abbreviations and Acronyms
SPJ  supercharged pedicled jejunumJejunal function was assessed through review of hospital records,
1392 The Journal of Thoracic and Cardiovascular Surgery ● Novas well as telephone interviews with the surviving patients. Spe-
cific issues addressed during these interviews included alterations
in eating habits, weight status, need for supplemental alimentation,
degree of dysphagia, reflux, dumping, and overall satisfaction with
the results of the operation. Patients were also questioned about the
need for conduit dilation or remedial procedures.
Operative Technique
All patients underwent esophageal reconstruction with a 1-stage pro-
cedure involving both the thoracic and microvascular plastic surgical
teams. Patients in whom the esophagus was intact underwent either a
transhiatal or 3-field esophagectomy with a cervical anastomosis.
At the time of laparotomy, the stomach was mobilized and
divided at the appropriate margin with a linear cutting stapler. A
gastric drainage procedure (either pyloroplasty or pyloromyotomy)
was routinely performed. The conduit was harvested from the
proximal jejunum beginning approximately 40 cm distal to the
ligament of Treitz. The mesentery of the jejunum was examined
with a fiberoptic light to transilluminate the tissues and identify the
blood vessel anatomy. The first branch vessel beyond the ligament
of Treitz was preserved. The fourth branch of the superior mes-
enteric artery functioned as the distal vascular pedicle to the
mobilized jejunal conduit. After test clamping demonstrated ade-
quate collateral circulation, the proximal mesenteric vessels of the
jejunal segment were ligated and divided close to their origin. The
mesentery of the jejunum was then divided to the serosal border
between the second and third mesenteric branches, allowing the
conduit to completely unfurl. This straightens the sinusoid turns in
the small bowel caused by a naturally foreshortened mesentery.
Eliminating this step can lead to redundancy and poor flap func-
tion. The bowel was divided with a linear cutting stapler.
The conduit was then brought through the chest in either a retro-
sternal or posterior mediastinal position. In patients who required a
retrosternal route, the thoracic inlet was enlarged. By using a sternal
saw, the manubrium was divided in the midline from the sternal notch
to the inferior level of the first rib. A perpendicular cut was next made
just inferior to the left first rib and carried to join the previously made
sternal incision. In this manner a portion of the manubrium, left
clavicular head, and left first rib were resected to allow the jejunum to
enter the neck without constriction. This approach also allowed access
to the internal thoracic artery and vein for the purposes of mesenteric
revascularization.
At this point, the conduit was trimmed to eliminate redundancy.
The cervical anastomosis was performed with a single layer of
interrupted 3-0 Vicryl sutures. A microvascular anastomosis was
then performed between the proximal jejunal mesenteric arcade
and either the internal thoracic vessels or branches of the external
carotid artery and jugular vein. Occasionally, a saphenous vein
graft was used to bridge a gap between the conduit and recipient
vessels.
In the abdomen the distal portion of the conduit was anasto-
mosed to the posterior wall of the stomach in a retrocolic retro-
gastric manner with a circular stapler. Jejunal continuity was
reestablished through a stapled anastomosis. In the absence of a
stomach, a Roux-en-Y anastomosis was performed. A nasogastric
tube was passed through the conduit and secured in place. A
feeding jejunostomy tube was routinely placed.
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the revascularized mesenteric arcade and then externalized through
the cervical wound to serve as a monitor flap. Once the interposed
flap was proved viable (5-7 days postoperatively) the monitor flap
was removed at the bedside by ligating and dividing its pedicle at
skin level. A schematic of the procedure is provided in Figure 1.
Postoperatively, patients recovered in the surgical intensive
care unit until they were deemed stable for transfer to the ward.
Enteral feeding was initiated as soon as possible. Patients routinely
had a contrast esophagram on day 7 or earlier if indicated. If no
leak was detected, the nasogastric tube was removed. Most pa-
tients were then started on a liquid diet and advanced to a post-
gastrectomy diet as tolerated.
Results
During the 4-year period, 26 patients were selected for
esophageal reconstruction with an SPJ flap. Patient demo-
graphics are listed in Table 1. Esophageal carcinoma was
TABLE 1. Demographics (n  26)
Age (y)
Mean 55.2
Median 55.1
Range 37-74.6
Sex
Male 18 (69.2%)
Female 8 (30.8%)
Primary
Esophageal cancer 22 (84.6%)
Other malignancy 4 (15.4%)
Tumor location
Cervical 4 (15.4%)
Middle 5 (19.2%)
Lower 5 (19.2%)
Gastroesophageal junction 10 (38.6%)
Stomach 1 (3.8%)
Other 1 (3.8%)
Esophageal cancer stage (n  22)
I 5 (22.7%)
IIA 6 (27.3%)
IIB 3 (13.7%)
III 7 (31.8%)
IVA 0
IVB 1 (4.5%)
Preoperative chemotherapy 13 (50%)
Preoperative radiation therapy
None 13 (50%)
45 Gy 6 (23.1%)
45 Gy 7 (26.9%)
Zubrod
0 2 (7.7%)
1 20 (76.9%)
2 3 (11.6%)
3 0
4 1 (3.8%)the predominant malignancy, and tumors were most com-
The Journal of Thoracicmonly encountered at the esophagogastric junction. More
than half of these patients had received neoadjuvant therapy
of some kind. The majority of patients were symptomatic
from their disease, as indicated in Table 2. Seven (26.9%)
patients had previous procedures that resulted in esophago-
gastric discontinuity.
Patient comorbidities are presented in Table 3. The com-
plex nature of this patient population is underscored by the
high percentage of patients who had undergone prior fore-
gut surgery, chemotherapy, and/or radiation therapy. De-
spite these facts, the overall performance status of the group
was very good.
Indications for the use of an SPJ flap were varied, as
indicated in Table 4. As experience was gained with this
technique, 3 patients were offered SPJ flap reconstruction as
a primary method of repair.
The operative results and complications are summarized
in Tables 5 and 6. Twenty-four of twenty-six patients were
ultimately discharged with an intact SPJ flap, for an overall
success rate of 92.3%. One patient experienced intraopera-
TABLE 2. Preoperative symptoms (n  26)
Anorexia 3 (11.5%)
Dysphagia
None 10 (38.5%)
Solids 8 (30.8%)
Liquids 1 (3.8%)
Discontinuity 7 (26.9%)
Reflux
None 14 (53.8%)
Mild 6 (23.1%)
Moderate 2 (7.7%)
Severe 4 (15.4%)
Weight loss 10 lbs 11 (42.3%)
TABLE 3. Comorbidities (n  26)
Smoker
Never 12 (46.1%)
Former 11 (42.3%)
Current 4 (15.4%)
Hypertension 7 (26.9%)
CAD 1 (3.8%)
Barrett’s esophagus 7 (26.9%)
Achalasia 1 (3.8%)
COPD 2 (7.7%)
Diabetes 2 (7.7%)
Prior malignancy 10 (38.5%)
Prior foregut operation 14 (53.8%)
Prior chemotherapy 6 (23.1%)
Prior radiation therapy 7 (26.9%)
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary
disease.tive flap loss caused by mesenteric arterial dissection during
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subsequently reconstructed with a gastric pull-up. One other
flap loss occurred during the early postoperative period in a
patient with abdominal compartment syndrome and multi-
system organ failure after a prolonged reconstruction. There
were 6 (23%) patients who were discharged without expe-
riencing any postoperative events. Cervical anastomotic
TABLE 4. Indications for use of jejunal flap (n  26)
Previous gastric surgery 5
Previous gastric radiation 2
Prior use of pedicled omental flap (absence of right
gastroepiploic artery)
2
Tumor involvement of stomach 4
High proximal resection line (proximal hypopharynx) 3
Failed pull-up with gastric necrosis 5
Recurrent tumor after esophagectomy 2
Primary repair 3
TABLE 5. Results
Esophagectomy type
Transhiatal 10 (38.5%)
Three field 11 (42.3%)
Prior resection 5 (19.2%)
Conduit location
Posterior mediastinum 13 (50%)
Retrosternal 13 (50%)
Mortality 0
Flap survival 24/26 (92.4%)
Operative time (h)
Mean 12.4
Median 12.1
Range 8-17
Estimated blood loss (mL)
Mean 1441
Median 1000
Range 250-6000
Patients transfused 16 (61.5%)
Length of stay (d)
Mean 23.8
Median 18
Range 10-73
Enteral intake at discharge
Solid 15 (57.8%)
Full liquid 3 (11.5%)
NPO 8 (30.7%)
Supplemental diet at discharge
Enteral 25 (96.2%)
None 1 (3.8%)
Discharge to
Home 21 (80.8%)
Rehab 5 (19.2%)
NPO, Nothing by mouth.leaks occurred in 5 (19.2%) patients, all of which resolved
1394 The Journal of Thoracic and Cardiovascular Surgery ● Novwith neck drainage and local wound care. Four of these
leaks occurred in patients with retrosternal conduits. Two
patients had delayed presentation of midconduit perfora-
tions. One of these was well drained by existing chest tubes
and resolved with conservative management. The other
required thoracotomy and primary repair. In both of these
patients, difficulty with passing the nasogastric tube through
the conduit likely caused these injuries. One additional
patient required early reoperation for an acute abdomen
caused by cecal ischemia. There were no operative, 30-day,
or in-hospital mortalities, and 80.8% (n  21) of patients
were discharged directly to home.
At the time of discharge, 69.3% (n  18) of the patients
were tolerating an oral diet. Only 8 patients were discharged
with orders to take nothing by mouth. One was because of
recurrent aspiration, and the remainder were because of
leaks. Ninety-six percent (n  25) of patients were dis-
charged with supplemental tube feeding.
Of the 24 patients successfully treated with an SPJ flap,
22 survived at least 6 months after their reconstruction. We
were able to obtain functional data in 95.4% (n  21) of
these cases, with an average potential follow-up of 32
months (Table 7). Twenty (95.2%) patients were tolerating
a regular diet. The number of meals per day ranged from 2
to 6. Only 23.8% (n  5) of the patients required prolonged
supplemental enteral nutrition. Thirteen patients reported
normal swallowing function. Five patients experienced oc-
casional mild dysphagia with certain solid foods, and 5
patients reported occasional mild dysphagia with liquids at
extremes of temperature. Contrast studies in these patients
demonstrated widely patent anastomoses without evidence
of stricture. These symptoms appeared to result from dif-
ferences in the rate of peristalsis between the residual
TABLE 6. Complications
Flap loss 2 (7.7%)
Early reoperation 2 (7.7%)
Leaks
Cervical anastomosis 5 (19.2%)
Midconduit perforation 2 (7.7%)
Arrhythmia 8 (30.7%)
Wound infection 7 (26.9%)
Pneumonia 6 (23.1%)
Pleural effusion 6 (23.1%)
Reintubation 5 (19.2%)
Recurrent nerve palsy 3 (11.5%)
Sepsis/MSOF 2 (7.7%)
ARDS 2 (7.7%)
Empyema 2 (7.7%)
MI 1 (3.8%)
DVT 1 (3.8%)
MSOF, Multiple systems organ failure; ARDS, adult respiratory distress
syndrome; MI, myocardial infarction; DVT, deep venous thrombosis.esophagus and the interposed jejunum. These symptoms
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symptoms were absent in 95.2% (n  20) of the patients,
and 80.9% (n  17) had no dumping symptoms.
Few patients have required remedial procedures. One
patient required repair of an incisional hernia. Dilation of a
midconduit stricture was required in 1 patient. One patient
presented 18 months after retrosternal interposition with
progressive reflux and regurgitation. Contrast studies and
endoscopy demonstrated obstruction from a redundant con-
duit. He was successfully managed with a stapled jejunoje-
junostomy, bypassing the redundant segment. Out of the 15
patients working before this operation, 6 (40%) have re-
turned to their previous professions. To date, 12 patients are
alive with no evidence of disease, 4 are alive with recurrent
disease, 7 are dead of their disease, and 3 are dead of other
causes.
Discussion
The stomach and colon have proved to be acceptable esoph-
ageal replacement conduits, although neither has emerged
as the ideal esophageal substitute. The stomach has a reli-
able blood supply, is relatively easy to pull up, and requires
just one anastomosis to complete the reconstruction. A
gastric conduit has specific disadvantages, however. The
normal stomach length, when fashioned as a conduit, might
not be consistently suitable for long-segment reconstruction
involving the proximal hypopharynx. Furthermore, gastric
interposition procedures might be associated with symptom-
atic reflux and positional regurgitation.6 Patients with an
TABLE 7. Function after 6 months (n  21)
Regular diet 20 (95.2%)
Tube feeds
None 16 (76.2%)
Partial 4 (19%)
Full 1 (4.8%)
Dysphagia
None 13 (61.9%)
Solids
Mild 5 (22.7%)
Severe 0
Liquids
Mild 5 (22.7%)
Severe 0
Stricture-dilation 1 (4.8%)
Reflux
None 20 (95.2%)
Mild 1 (4.8%)
Severe 0
Dumping
None 17 (80.9%)
Mild 3 (14.3%)
Severe 1 (4.8%)intrathoracic esophagogastric anastomosis can experience
The Journal of Thoracicmetaplastic changes in the mucosa of the residual esopha-
gus.7,8 These changes can progress to significant dysplasia
or recurrent malignancy requiring additional treatment.
Pedicled colon can provide adequate length for total
esophageal reconstruction and might alleviate some of the
problems that arise in the long term after gastric interposi-
tion. Colon interposition, however, is not free from compli-
cation. The development of conduit redundancy over time
impairs food transit, leading to an unpleasant sensation of
fullness, troublesome regurgitation, and the need for reme-
dial operations.2-5 The vascular anatomy is variable and can
be adversely affected by atherosclerosis. Colonic necrosis,
thought to result from arterial or venous insufficiency at the
oral end of the pedicle,9 carries a significant mortality risk.10
In a distinct subset of patients, traditional gastric or
colonic conduits are not available as esophageal replace-
ments, either because of intrinsic disease, tumor involve-
ment, or previous surgical intervention. Esophageal recon-
struction in this group can prove daunting. In these patients
we have evaluated the jejunum as an alternative conduit for
total esophageal reconstruction.
The long-term durability of jejunum is well estab-
lished.11 It is available in sufficient quantity and can be
harvested with limited physiologic effect on gastrointestinal
function. Jejunum is relatively free of intrinsic disease and
provides a sterile conduit. It more closely approximates the
diameter of native esophagus and also retains its peristaltic
activity after transfer. Although the value and effectiveness
of this peristalsis has been questioned,12 several studies
have supported the functional importance of these contrac-
tions when compared with the passive colonic conduit.13-15
Esophageal reconstruction with a jejunal conduit is well
described. Alexis Carrel reported his initial work on trans-
planting autologous small bowel into the necks of dogs in
1906.16 The first successful use of jejunum for esophageal
reconstruction in a human patient was reported by Roux in
1907,17 although the final stage of that reconstruction was
not completed until 1911. By then, Yudin18 had used
Roux’s pedicled reconstruction technique with good results
in an additional 11 patients and would use this technique in
a total of 80 patients by 1944. Despite his initial success, he
advocated caution, noting that variability in small bowel
vascular anatomy might preclude the use of this reconstruc-
tion in many patients. Caution was warranted, as demon-
strated by Ochsner and Owens.19 Their review of the liter-
ature on Roux’s technique up to 1934 noted that gangrene of
the jejunal loop occurred in 22% of the reported cases.
Inadequate conduit blood supply was thought to be the
principal reason for the high failure rate. Influenced by this
report, Longmire20 modified Roux’s technique in 1946
while treating a patient with a cicatricial esophageal ob-
struction after lye ingestion. To reduce the chances of flap
necrosis, he incorporated microvascular anastomoses be-
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internal thoracic vessels, thereby successfully augmenting
its circulation. In 1956, Androsov21 reported using this
vascular augmentation technique during esophageal recon-
struction in 11 patients. Although these reports demon-
strated that long-segment esophageal reconstruction with
supercharged jejunum was possible, the technical complex-
ities of the operation precluded its widespread acceptance.
Subsequent use of jejunum was predominantly limited to
short-segment repairs.
Refinement of microsurgical technique over the past 50
years has allowed surgeons to reconsider the supercharged
technique advocated by Longmire. The published reports
to date have shown encouraging results; however, most
of these series were small, with varied indications and
methods.22-27
Our series focuses on supercharged jejunum and its use
in a complex group of 26 patients with cancer with limited
reconstructive options. Many had prior malignancies and
numerous prior operations. A significant number of these
Figure 1. Completed augmented pedicled jejunal reconstruction.patients also received chemotherapy, radiation therapy, or
1396 The Journal of Thoracic and Cardiovascular Surgery ● Novboth. Despite these challenges, we were able to perform
successful reconstructions in 24 (92.4%) of 26 of these
patients by using the SPJ flap technique, with no mortality.
Postoperative morbidity proved to be higher than in other
series; however, most of the postoperative events were
minor in nature. Of the 5 cervical anastomotic leaks, 2 were
in salvage patients who had undergone previous definitive
chemoradiation therapy to the head and neck, and 3 were in
patients with esophagogastric discontinuity. Our leak rate
compares with what has been reported in the literature for
salvage and discontinuity patients.28-30 All of these anasto-
moses healed with conservative management, and none
required dilation.
From a functional standpoint, the SPJ conduit proved
very successful. Six months after the operation, more than
95% of patients had resumed a regular diet. Most patients
reported normal swallowing. Those with occasional dyspha-
gia classified it as mild and generally avoidable with dietary
discretion. The majority were free from the reflux and
dumping symptoms that can often follow esophagectomy.
Although functional benefits exist, caution is advocated
when considering this technique for primary repair in the
presence of a viable stomach. Experience has allowed us to
expand the application of this technique within our practice;
however, it remains a technically demanding operation best
suited for patients with no other reconstructive options.
The supercharged pedicled jejunal flap provides highly
selected patients with a suitable alternative conduit for total
esophageal reconstruction when traditional replacement
conduits are not available or appropriate. This procedure
can provide excellent functional outcomes, despite the tech-
nical challenges in this complex patient population.
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Discussion
Dr Joseph I. Miller, Jr (Atlanta, Ga). I wish to congratulate the
authors on a remarkable surgical forte in this group of highly
complex and technically challenging patients.
The value of the presentation is to look at the complexity of the
patients presented, with their previous surgical history, comorbidi-
ties, and previous chemoradiotherapy. They presented 26 patients,
of whom 24 were discharged with an intact supercharged pedicled
The Journal of Thoracicjejunal flap, for a 92.3% success rate, which is indeed a remarkable
feat. One really has to read the article to appreciate the complexity
of the cases. The use of stomach and colon when available is well
documented in the article, and the indications for use of the
supercharged flap are well outlined.
I have several questions for the author. Could you be a little
more specific in what supercharging means? As I read the article,
it seems that you have used standard microvascular techniques
with the internal thoracic and cervical vessels.
Dr Ascioti. The term supercharged is taken from our plastic
surgical colleagues. It is merely another term for a microvascular
augmentation. The entire circulation to the proximal jejunal seg-
ment is based on that microvascular anastomosis, whereas the
distal jejunum derives its blood supply from the pedicle within the
abdomen.
Dr Miller. Thank you.
How exactly is the anastomosis constructed, still leaving a
monitor flap? Do you worry about ligating that and then having
some sort of retrograde infection back to your anastomosis? Would
you comment on leaving the monitor flap or exactly how you can
construct the anastomosis?
Dr Ascioti. The monitor flap is merely fashioned from the
redundant bowel that is brought up into the neck. The mesentery of
that flap is based on the same mesentery that is perfused by the
microvascular anastomosis. Therefore we merely divide the mes-
entery to allow that flap to be mobile and reside outside the neck
wound. The blood supply to both the interposed jejunum, as well
as the monitor flap, is one and the same, and after about 5 days, we
are able just to ligate that pedicle without affecting the blood
supply to the residual interposition.
Dr Miller. In your article you stated that the cervical anasto-
mosis was done with one layer of interrupted 3-0 Vicryl sutures.
Your cervical leak rate is fairly high, greater than 19%. Granted,
they all did well with conservative management. Have you con-
sidered using Orringer’s technique with the Endo-30 stapler? His
leak rate went from 15% to 17% down to approximately 2%.
Dr Ascioti. In selected patients end-to-end anastomosis was
the only possible way of doing it. The size match is most
appropriate in that manner. In certain patients a stapled anas-
tomosis might be possible, and we are looking into that after
having looked over our data in the past 4 years.
Dr Miller. In the article the mean operative time was approx-
imately 12 hours, with the longest being 18 hours. Is this due to the
reentry problems, is it trouble with a flap harvest, or is it due to the
plastic surgeons with their microvascular technique?
Dr Ascioti. A lot of the time in these patients can be spent on
reentry and flap mobilization. We are very careful to orient the flap
correctly as it is brought through the chest to ensure that the
pedicle is not kinked in any way and to make sure that the blood
vessels line up appropriately. The microvascular anastomosis
takes, on average, usually a little over an hour for just the arterial
and venous anastomosis to be done.
Dr Miller. In conclusion, this is an outstanding article and a
remarkable surgical achievement. The authors are to be congratu-
lated.
Dr Ascioti. Thank you, Dr Miller.
Dr David H. Harpole, Jr (Durham, NC). This is an elegantstudy. I guess the only question I had I could not get from your
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TSpresentation. You have the monitor flap there that you are looking
at. Did you follow this? Were there reoperations for ischemia that
you saw that were demonstrated by the small monitor flap? If you
did not have any in 20 cases, I am kind of wondering why you need
the monitor flap. Why couldn’t you just put some flow probes
down through the wound on the microvascular anastomosis, which
you could pull out through the wound in a couple days, you know,
to be able to follow the anastomosis itself or the bowel?
Dr Ascioti. Thank you for the question.
The monitor flap is a very accurate way to monitor both arterial
and venous problems, and because we can often be fooled by the
presence of arterial symptoms, that does not always prove to us
that there is not a problem with the venous circulation. Therefore
it allowed us a very simple and easy way to do that, which we were
able to provide for the patients.
Dr Mark S. Allen (Rochester, Minn). How do you reassure the
patients preoperatively when they wake up and see a segment of
exposed jejunum in their neck?
Dr Ascioti. We tell them it is only going to be there for a few
days. They do not seem to mind.
Dr Harpole. How many times did you re-explore on the basis
of the flap?
Dr Ascioti. We did not. There were no patients who had any
problems. There was one patient who we took back, the patient
who lost the conduit within 3 days after the operation because of
multisystem organ failure. She had persistent arterial inflow but
had a problem with venous congestion, and that patient prompted
us to take the flap out.
Dr John E. Foker (Minneapolis, Minn). I would like to com-
pliment you on an excellent article.
Twenty years ago, we presented to this Association a series of
long-segment jejunal interpositions followed for up to 33 years.
There had been no graft failures, and all were eating normally. At
least one is still eating well 50 years later. Also, as you probably
know, jejunal interpositions are the only grafts to maintain peri-
stalsis. At the same time, we described how to take down the
arcades to gain a great deal of length, enough to easily reach the
neck and to reduce redundancy.
Two years ago, I simplified the procedure by first dividing the
left triangular hepatic ligament and used the ligament to move the
left lobe of the liver out of the way. Then the jejunal limb was
brought through the right hemidiaphragm, in front of the right
hilum, up high in the chest. This proved to be an excellent
approach, which simplified the procedure.
My question is this: Given the far superior performance of the
jejunum and lack of serious consequences, such as reflux, dump-
ing, malnutrition, atrophic gastritis, et cetera, et cetera, why not use
it preferentially, particularly in those with a longer expected sur-
vival?
Dr Ascioti. Thank you for the question.
I think at Anderson our preferred conduit is still the stomach,
but we are looking at the use of jejunum in selected patients
because of concerns with intrathoracic gastric pull-up and the
incidence of reflux and potential for future metaplasia and dyspla-
sia within the residual esophagus, and we have been incorporating
the use of jejunum as an interposition in vagal-sparing esophage-
ctomies. We are evaluating that thoroughly, but I still think that it
1398 The Journal of Thoracic and Cardiovascular Surgery ● Novis a very large operation that should be required only in certain
circumstances in which traditional conduits are not available.
Dr Foker. It does not have to be.
Dr Steven R. DeMeester (Los Angeles, Calif). That was a very
elegant presentation.
I have 2 quick questions. Did you use any antiplatelet therapy
or anticoagulation early or long-term postoperatively in these
patients?
Dr Ascioti. The patients were only maintained on subcutaneous
heparin postoperatively.
Dr DeMeester. Second, can you describe for us the distal
connections? Was it all to Roux limbs, or did you connect to the
stomach? How did you construct distally?
Dr Ascioti. It depended on the anatomy within the stomach.
Obviously in patients without a gastric remnant, we did a Roux-en-Y,
and in patients with a partial gastric remnant, we would connect up
to that.
Dr DeMeester. How much of a gastric remnant would you
recommend leaving? Did you have problems with reflux or regur-
gitation or with strictures from acid complications if you left too
much stomach?
Dr Ascioti. No. We did not experience any complications at the
distal anastomosis. We hooked into whatever was left.
Dr Pasquale Ferraro (Montreal, Quebec, Canada). Do you
have any experience with the short jejunal segment? We have done
5 or 6 with the ear, nose, and throat surgeon, and instead of doing
a gastric interposition, we just used a free flap with the jejunum to
reconstruct the cervical esophagus. One comment, we also used
the monitor flap, just as you showed it, and it works very nicely.
Dr Ascioti. Thank you for your question.
We have used a free jejunal segment interposition in patients who
have a cervical recurrence after a colon interposition. We had a couple
cases in which we have done that, and the ear, nose, and throat
surgeons have some experience working with our plastic surgeons
with jejunal free interpositions for short-segment resections.
Dr Raphael Bueno (Boston, Mass). I enjoyed your presentation.
Where would you place a colon interposition in your armamen-
tarium? It seemed to me that in some of the cases that you
demonstrated, all the problems were with the stomach not being
available for interposition. It was not clear that the colon might not
have been available.
Dr Ascioti. Thank you, Dr Bueno. That is a very good ques-
tion.
In the initial operation in which we used this technique, the
patient had a previous gastric wrap with Marlex mesh, and every-
thing was very adherent to the stomach, including the transverse
colon, splenic flexure, spleen, and omentum, and by the time the
stomach was resected and the esophagus was resected, the colon
was rather beat up and not, we thought, appropriate for a colon
interposition. It was at that point we decided to use the jejunal
technique. Subsequent to that, we had taken patients to the oper-
ating room prepared to use either jejunum or colon, and the
decision was made intraoperatively on the basis of the size of the
colon, the bulkiness of the potential conduit, and other factors that
we went with jejunum. Once we started to realize the functional
outcomes that we were achieving with the jejunum, we became
more interested in looking at this as an alternative to the colon.
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